WallStreetZenWallStreetZen

NYSEMKT: RGNT
Regentis Biomaterials Revenue

OverviewEarningsRevenue
DividendOwnership
Regentis Biomaterials revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RGNT annual revenue was $0.0, with N/A growth year-over-year.

RGNT revenue history

Current Revenue
$0.0
Current Earnings
-$13.6M
Current Profit Margin
0%

Be the first to know when RGNT announces revenue.

RGNT Revenue History By Year

RGNT Yearly RevenueRGNT RevenueRGNT ChangeRGNT Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A

1 of 1

Regentis Biomaterials Revenue FAQ

What was RGNT's revenue last quarter?

Regentis Biomaterials (NYSEMKT: RGNT) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Regentis Biomaterials's revenue was N/A.

What was Regentis Biomaterials's revenue in 2025?

Regentis Biomaterials's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Regentis Biomaterials make in a day?

Based on Regentis Biomaterials annual revenue for the past two years, RGNT makes an average of $0.00 per day.

What was Regentis Biomaterials's annual revenue growth in the past year?

As of Q1 2026, Regentis Biomaterials's revenue has grown null year over year. Regentis Biomaterials's revenue in the past year totaled $0.00.

How much does Regentis Biomaterials make in a year?

Regentis Biomaterials's revenue by year for the past two years is:
  • Regentis Biomaterials's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Regentis Biomaterials's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.